XML 56 R41.htm IDEA: XBRL DOCUMENT
v3.25.4

Accrued Liabilities an Other Long-term Liabilities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Accrued Liabilities and Other Liabilities [Abstract] |
Schedule of Accrued Liabilities [Table Text Block] | Accrued liabilities consist of the following (in thousands):
|  | As of December 31,
|  | 2025 |  | 2024
Salaries and benefits |  | $ | 70,526 |  |  | $ | 60,815 |
Incentive compensation |  | 60,799 |  |  | 59,445 |
Deferred revenue |  | 33,843 |  |  | 30,358 |
Italy medical device payback provision(1) |  | 24,597 |  |  | 23,937 |
Field service corrective action(2) |  | 27,777 |  |  | 32,844 |
Other |  | 97,795 |  |  | 99,524 |
|  | $ | 315,337 |  |  | $ | 306,923 |
_____________________________ (1) Related to potential payments associated with the Italy Medical Device Payback ("IMDP") as a result of 2015 legislation enacted requiring medical device companies to make payments to the Italian government based on regional expenditure ceilings (see Note 15: Commitments and Contingencies for further details). (2) Primarily includes field corrective actions associated with certain products in connection with a 2021 Warning Letter (as defined below) received by Smiths Medical from the FDA following an inspection of Smiths Medical's Oakdale, Minnesota Facility (see Note 15: Commitments and Contingencies for further details).

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration